Sumayang, Nolasco L.
HRN: 24-37-97 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/10/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/10/2024
02/09/2024
IV
600mg
Q6
Cellulitis Left Leg
Checking Final Appropriateness
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes